EUVIMEDEUVIMED entdecken
FallberichtOpen Access

Cannabidiol as a personalized treatment for anxiety: clinical cases in Mexico

Flor Cristina Ortiz Rios iD, Itzel Guadalupe Dávila Ruiz, Elisa Sacal Dumani

Drugs in Context · 19.09.2022 · 11 · 1-14

DOI: 10.7573/dic.2022-3-2 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Drugs in Context, online erschienen am 19.09.2022. Verfasst von Flor Cristina Ortiz Rios und 2 weiteren Autor:innen. Beteiligte Einrichtung: ICAN Instituto del Cannabis, Mexico City, Mexico. Die Arbeit wurde bisher 6-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

CBDanxietycannabidioldelta-9-tetrahydrocannabinolendocannabinoid systeminsomniamedical cannabis

Autor:innen und Institutionen

  • ICAN Instituto del Cannabis, Mexico City, Mexico.
  • Private practice, CEO & Cofounder of the Family Sleep Institute - Spanish (FSI), Cofounder of the Asociación Mexicana de Medicina de Estilo de Vida, Mexico City, Mexico.

ORCID-Profile: Flor Cristina Ortiz Rios

Zitieren

APA

Ortiz Rios, F. C., Dávila Ruiz, I. G., & Sacal Dumani, E. (2022). Cannabidiol as a personalized treatment for anxiety: clinical cases in Mexico. Drugs in Context, 11, 1-14. https://doi.org/10.7573/dic.2022-3-2

Vancouver

Ortiz Rios FC, Dávila Ruiz IG, Sacal Dumani E. Cannabidiol as a personalized treatment for anxiety: clinical cases in Mexico. Drugs in Context. 2022;11:1-14. doi:10.7573/dic.2022-3-2

BibTeX
@article{OrtizRios2022,
  author = {Ortiz Rios, Flor Cristina and Dávila Ruiz, Itzel Guadalupe and Sacal Dumani, Elisa},
  title = {Cannabidiol as a personalized treatment for anxiety: clinical cases in Mexico},
  journal = {Drugs in Context},
  year = {2022},
  volume = {11},
  pages = {1--14},
  doi = {10.7573/dic.2022-3-2}
}
Kostenlos starten →